0
0

Chapter 50. Alpha-Adrenergics, Beta-Blockers, Benzodiazepines, Buspirone, and Desmopressin

Lawrence Scahill, M.S.N., Ph.D.; Yann Poncin, M.D.; Alexander Westphal, M.D.
DOI: 10.1176/appi.books.9781585623921.474993

Sections

Excerpt

With the exception of desmopressin, the medications reviewed in this chapter were developed and tested in adults and later adapted for use in pediatrics. They are a heterogeneous collection of drugs with specialized indications for children and adolescents. The evidence supporting the use of these drugs varies widely.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Table Reference Number
TABLE 50–1. Pediatric oral dosing guidelines for benzodiazepines for anxiety

References

Adler LA, Angrist B, Weinreb H, et al: Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease. Psychopharmacol Bull 27:107–111, 1991
[PubMed]
 
Arnsten AF, Scahill L, Findling RL: Alpha2-adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol 17:393–406, 2007
[PubMed]
 
Ballesteros J, Callado LF: Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J Affect Disord 79:137–147, 2004
[PubMed]
 
Baumeister AA, Sevin JA: Pharmacologic control of aberrant behavior in the mentally retarded: toward a more rational approach. Neurosci Biobehav Rev 14:253–262, 1990
[PubMed]
 
Biederman J, Melmed RD, Patel A, et al: A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics 121:e73–e84, 2008
 
Blier P: Pharmacology of rapid-onset antidepressant treatment strategies. J Clin Psychiatry 62(suppl):12–17, 2001
 
Boon-Yasidhi V, Kim YS, Scahill L: An open-label, prospective study of guanfacine in children with ADHD and tic disorders. J Med Assoc Thai 88(suppl):S156–S162, 2005
 
Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, et al: Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder: clinical efficacy and side-effects. J Child Psych Psychiatry 37:587–595, 1996
[PubMed]
 
Buitelaar JK, van der Gaag RJ, van der Hoeven J: Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry 59:56–59, 1998
[PubMed]
 
Chappell PB, Riddle MA, Scahill L, et al: Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Child and Adolesc Psychiatry 34:1140–1146, 1995
[PubMed]
 
Chessick CA, Allen MH, Thase ME, et al: Azapirones for generalized anxiety disorder. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD006115. DOI: 10.1002/14651858.CD006115
 
Ciraulo DA, Shader RI, Greenblat DJ, et al: Drug Interactions in Psychiatry, 3rd Edition. Philadelphia, PA, Lippincott Williams & Wilkins, 2006
 
Cohen DJ, Young JG, Nathanson JA, et al: Clonidine in Tourette's syndrome. Lancet 2:551–553, 1979
[PubMed]
 
Cummings DD, Singer HS, Krieger M, et al: Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 25:325–332, 2002
[PubMed]
 
Daviss WB, Patel NC, Robb AS, et al: Clonidine for attention-deficit/hyperactivity disorder, II: ECG changes and adverse events analysis. J Am Acad Adolesc Psychiatry 47:189–198, 2008
[PubMed]
 
Fischel T, Hermesh H, Aizenberg D, et al: Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study. J Clin Psychopharmacol 21:612–615, 2001
[PubMed]
 
Gaffney GR, Perry PJ, Lund BC, et al: Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 41:330–336, 2002
[PubMed]
 
Glazener CM, Evans JH: Desmopressin for nocturnal enuresis in children. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD002112. DOI: 10.1002/14651858.CD002112
 
Gogtay N, Sporn A, Alfaro CL, et al: Clozapine-induced akathisia in children with schizophrenia. J Child Adolesc Psychopharmacol 12:347–349, 2002
[PubMed]
 
Graae F, Milner J, Rizzotto L, et al: Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:372–376, 1994
[PubMed]
 
Hidalgo RB, Tupler LA, Davidson JR: An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 21:864–872, 2007
[PubMed]
 
Hoffman BB: Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edition. Edited by Hardman JG, Limbird LE, Gilman AG. New York, McGraw-Hill, 2001, pp 215–268
 
Horrigan JP, Barnhill LJ: Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 5:215–223, 1995
 
Hunt RD, Arnsten AF, Asbell MD: An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50–54, 1995
[PubMed]
 
Leckman JF, Hardin MT, Riddle MA, et al: Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48:324–328, 1991
[PubMed]
 
Leo RJ: Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 57:449–454, 1996
[PubMed]
 
Lottmann H, Froeling F, Alloussi S, et al: A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis. Int J Clin Pract 61:1454–1460, 2007
[PubMed]
 
Norgaard JP, Hashim H, Malmberg L, et al: Antidiuresis therapy: mechanism of action and clinical implications. Neurourol Urodyn 26:1008–1013, 2007
[PubMed]
 
Palumbo DR, Sallee FR, Pelham WE, et al: Clonidine for attention-deficit/hyperactivity disorder, I: efficacy and tolerability outcomes. J Am Acad Adolesc Psychiatry 47:180–188, 2008
[PubMed]
 
Pitman RK, Sanders KM, Zusman RM, et al: Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51:189–192, 2002
[PubMed]
 
Pollack MH: Social anxiety disorder: designing a pharmacologic treatment strategy. J Clin Psychiatry 60(suppl):20–26, 1999
 
Poncin Y, Scahill L: Stimulants and nonstimulants in the treatment of hyperactivity in autism, in Clinical Manual for the Treatment of Autism. Edited by Hollander E, Anagostou E. Washington, DC, American Psychiatric Publishing, 2007, pp 131–147
 
Ratey JJ, Gordon A: The psychopharmacology of aggression: toward a new day. Psychopharmacol Bull 29:65–73, 1993
[PubMed]
 
Reiner W: Pharmacotherapy in the management of voiding and storage disorders, including enuresis and encopresis. J Am Acad Adolesc Psychiatry 47:491–498, 2008
[PubMed]
 
Rynn MA, Ryan J: Anxiety disorders, in Clinical Manual of Child and Adolescent Psychopharmacology. Edited by Findling RL. Washington, DC, American Psychiatric Publishing, 2008, pp 143–196
 
Sahoo S, Ameen S: Acute nocturnal akathisia induced by clozapine. J Clin Psychopharmacol 27:205, 2007
[PubMed]
 
Scahill L, Chappell PB, Kim YS, et al: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067–1074, 2001
[PubMed]
 
Scahill L, Aman MG, McDougle CJ, et al: A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol 16:589–598, 2006a
 
Scahill L, Erenberg G, Berlin CM, et al: Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 3:192–206, 2006b
 
Schur SB, Sikich L, Findling RL, et al: Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY), part I: a review. J Am Acad Child Adolesc Psychiatry 42:132–144, 2003
[PubMed]
 
Simeon JG, Ferguson HB, Knott V, et al: Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 31:29–33, 1992
[PubMed]
 
Tallman JF, Cassella J, Kehne J: Mechanism of action of anxiolytics, in Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, et al. Philadelphia, PA, Lippincott Williams & Wilkins, 2002, pp 993–1006
 
Tourette's Syndrome Study Group: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 58:527–536, 2002
[PubMed]
 
Voshaar RC, Couvee JE, van Balkom AJ, et al: Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry 189:213–220, 2006
[PubMed]
 
+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Research suggests that guanfacine may be useful for treatment of the hyperactivity, impulsiveness, and distractibility associated with which of the following disorders?
2.
Clonidine may be an effective treatment for which of the following disorders?
3.
Prior to beginning an alpha-2 agonist and during treatment, which of the following clinical areas should be evaluated or tests obtained?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 36.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 2.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 3.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 4.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation